Location History:
- Laval, CA (2004 - 2007)
- Terrebonne, CA (2007 - 2010)
Company Filing History:
4 out of 62 
1 out of 1,536 
Years Active: 2004-2010
Title: The Innovative Contributions of Daniel Lamarre
Introduction
Daniel Lamarre is a notable inventor based in Terrebonne, CA. He has made significant contributions to the field of biotechnology, particularly in the development of assay systems for hepatitis C virus research. With a total of 5 patents to his name, Lamarre's work has the potential to impact the pharmaceutical industry and improve therapeutic strategies.
Latest Patents
One of Lamarre's latest patents is titled "Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease." This invention focuses on creating a cell-based assay system that demonstrates improved sensitivity to HCV NS3 protease activity compared to existing assays. The system is designed to screen test compounds that can modulate, particularly inhibit, HCV NS3 protease activity. It includes a first construct with a transactivator domain linked to the NS3-5 domains of HCV, controlled by a non-cytopathic viral promoter system. Additionally, a second construct features a reporter gene regulated by an operator sensitive to the transactivator's binding. The NS3-5 domains encode the NS3 polyprotein, which consists of the NS3 protease, NS4A co-factor, NS4B, and NS5A proteins, culminating in a cleavage site with the NS5B protein. The transactivator initiates transcription and expression of the reporter gene, which can be measured.
Career Highlights
Throughout his career, Daniel Lamarre has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Boehringer Ingelheim (Canada) Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex biological challenges.
Collaborations
Lamarre has collaborated with several professionals in his field, including Charles Pellerin and Louise Pilote. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented technologies.
Conclusion
Daniel Lamarre's innovative work in the biotechnology sector, particularly in developing assays for hepatitis C virus research, showcases his significant contributions to the field. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving healthcare solutions.